Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women
Author:
Affiliation:
1. Pharmacoepidemiology Berlin, Berlin, Germany;
2. ZEG, Berlin Center for Epidemiology and Health Research, Berlin, Germany
Funder
Bayer
Publisher
Informa UK Limited
Subject
Obstetrics and Gynecology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13697137.2016.1183624
Reference28 articles.
1. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
3. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation
4. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives
5. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Blackcurrant extract promotes differentiation of MC3T3‑E1 pre‑osteoblasts;Biomedical Reports;2024-06-19
2. Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia;Bulletin of Reproductive Health;2024-06-18
3. Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia;Problems of Endocrinology;2023-11-12
4. Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP;Kardiologiia;2023-11-08
5. The use of menopausal hormone therapy in women at high cardiovascular risk;"Arterial’naya Gipertenziya" ("Arterial Hypertension");2022-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3